DermTech, Inc. DMTK
Set alert
0.09 0.00 0.00%
At close · Jun 26
0.089 Day range 0.1002
52-week range unavailable
- Open
- 0.099
- Prev close
- 0.094
- Mkt cap
- 3.29M
- Vol
- 3.40M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.089
- High
- 0.1002
- Forward P/E
- -0.05
- Beta
- 2.42
- Short ratio
- 2.64
- Inst. own
- 18.09%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 1, 2024
- 50-d avg
- 0.310556
- 200-d avg
- 0.970113
- 1y target
- 1.50
5Y chart
Events in this range
- Aug 16, 2022Rating: Oppenheimer · — → Outperform
- Nov 3, 2022Downgrade: William Blair · Outperform → Market Perform
- Nov 8, 2022Rating: Stephens & Co. · — → Overweight
- Mar 28, 2023Rating: TD Cowen · — → Outperform
- May 4, 2023Earnings: —; estimate -0.9; surprise —%
- Aug 3, 2023Earnings: —; estimate -0.95; surprise —%
- Aug 6, 2023Rating: BTIG · Buy → Buy
- Nov 2, 2023Earnings: —; estimate -0.68; surprise —%
- Feb 29, 2024Earnings: —; estimate -0.54; surprise —%
- May 14, 2024Earnings: —; estimate 0; surprise —%
Signals (40)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Jun 24, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 17, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 3, 2024 | 2 years ago |
| RSI: Oversold | May 17, 2024 | 2 years ago |
| MACD: Buy Signal | May 3, 2024 | 2 years ago |
| RSI: Oversold | Apr 26, 2024 | 2 years ago |
| RSI: Oversold | Apr 5, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 14, 2024 | 2 years ago |
| SMA: Bearish | Jan 4, 2024 | 2 years ago |
| SMA: Bullish | Dec 21, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 15, 2023 | 2 years ago |
| SMA: Bullish | Nov 8, 2023 | 2 years ago |
| MACD: Sell Signal | Aug 29, 2023 | 3 years ago |
| SMA: Bearish | Aug 8, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 11, 2023 | 3 years ago |
| SMA: Bullish | Jul 3, 2023 | 3 years ago |
| SMA: Bearish | Jun 20, 2023 | 3 years ago |
| SMA: Bullish | Jun 13, 2023 | 3 years ago |
| MACD: Sell Signal | May 9, 2023 | 3 years ago |
| SMA: Bearish | May 2, 2023 | 3 years ago |
Newest 20 of 40.
Analyst view
Consensus: hold
Hold
Price target (mean) 1.50
Ratings (-1m) 4 2 buy · 2 hold · 0 sell
- Strong buy0
- Buy2
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 4
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.52 | -0.52 – -0.52 | -0.99 | +47.5% | 3.95M | +7.0% | 1 |
| Next quarter | -0.52 | -0.52 – -0.52 | -0.57 | +8.8% | 4.19M | 0.0% | 1 |
| Current year | -2.12 | -2.12 – -2.12 | -3.09 | +31.4% | 16.20M | +5.9% | 1 |
| Next year | -2.08 | -2.08 – -2.08 | -2.12 | +1.9% | 17.40M | +7.4% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 6, 2023 | BTIG | Maintained | Buy | Buy |
| Mar 28, 2023 | TD Cowen | Maintained | — | Outperform |
| Nov 8, 2022 | Stephens & Co. | Maintained | — | Overweight |
| Nov 7, 2022 | BTIG | Maintained | — | Buy |
| Nov 3, 2022 | William Blair | Downgrade | Outperform | Market Perform |
| Aug 16, 2022 | Oppenheimer | Maintained | — | Outperform |
| Aug 14, 2022 | BTIG | Maintained | — | Buy |
| Jan 6, 2022 | Stephens & Co. | Initiated | — | Overweight |
| May 2, 2021 | BTIG | Initiated | — | Buy |
| Jan 21, 2021 | Oppenheimer | Initiated | — | Outperform |
| Oct 29, 2020 | William Blair | Initiated | — | Outperform |
| Sep 9, 2020 | Cowen & Co. | Initiated | — | Outperform |